
Please try another search
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company’s immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
Jean-Charles Soria | 50 | 2020 | Director |
Daniel D. Pinschewer | 49 | 2011 | Co-Founder & Member of Scientific Advisory Board |
Paul-Henri Lambert | 86 | 2011 | Member of Scientific Advisory Board |
Igor Matushansky | 52 | 2017 | Chairman of the Scientific Advisory Board |
David Ross Kaufman | 51 | 2019 | Independent Director |
Julie O'Neill | 59 | 2018 | Independent Non-Executive Chair |
Mary Theresa Coelho | 63 | 2023 | Executive VP, CFO & Director |
Sean A. Cassidy | 55 | 2024 | Independent Director |
Malte Peters | 63 | 2023 | CEO, President & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review